SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.68 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $367,000 | -61.2% | 2,154 | -68.0% | 0.01% | -68.4% |
| Q3 2020 | $946,000 | -54.1% | 6,734 | -47.6% | 0.02% | -62.0% |
| Q2 2020 | $2,060,000 | +674.4% | 12,850 | +371.9% | 0.05% | +455.6% |
| Q1 2020 | $266,000 | -66.3% | 2,723 | -55.5% | 0.01% | -57.1% |
| Q4 2019 | $790,000 | -90.1% | 6,123 | -88.3% | 0.02% | -91.6% |
| Q2 2019 | $7,956,000 | +38.7% | 52,360 | +8.8% | 0.25% | +15.8% |
| Q1 2019 | $5,738,000 | +49.2% | 48,140 | +36.6% | 0.22% | +30.3% |
| Q4 2018 | $3,847,000 | -46.1% | 35,248 | -20.2% | 0.16% | -25.0% |
| Q3 2018 | $7,134,000 | -17.9% | 44,170 | -32.8% | 0.22% | -25.2% |
| Q2 2018 | $8,690,000 | +115.1% | 65,746 | +20.6% | 0.29% | +105.6% |
| Q1 2018 | $4,040,000 | -9.8% | 54,529 | -32.2% | 0.14% | -15.9% |
| Q4 2017 | $4,477,000 | +35.3% | 80,466 | +10.3% | 0.17% | +31.8% |
| Q3 2017 | $3,309,000 | +44.2% | 72,956 | +95.2% | 0.13% | +65.4% |
| Q3 2016 | $2,295,000 | +10.0% | 37,375 | -15.4% | 0.08% | -3.7% |
| Q3 2013 | $2,086,000 | +8.0% | 44,170 | -13.1% | 0.08% | -3.6% |
| Q2 2013 | $1,932,000 | – | 50,802 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |